GPR50 interacts with neuronal NOGO-A and affects neurite outgrowth

Molecular and Cellular Neuroscience

Volumn 42, Issue 4, 2009, Pages 363-371

  Grünewald, Ellen ^a   Kinnell, Hazel L ^b   Porteous, David J ^a   Thomson, Pippa A ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

GPR50; Melatonin related receptor; Neurite outgrowth; Neuronal NOGO A; Orphan receptor; Postsynaptic density

Indexed keywords

G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 50; PROTEIN NOGO; PROTEIN NOGO A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL DENSITY; CELL SIZE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EMBRYO; FILOPODIUM; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; KNOCKOUT MOUSE; LAMELLIPODIUM; MALE; MENTAL DISEASE; MOUSE; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NONHUMAN; NUCLEOTIDE SEQUENCE; POSTSYNAPTIC MEMBRANE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RAT;

AMINO ACID SEQUENCE; ANIMALS; BRAIN; CELL LINE; FEMALE; HUMANS; MICE; MOLECULAR SEQUENCE DATA; MYELIN PROTEINS; NERVE TISSUE PROTEINS; NEURITES; RECEPTORS, G-PROTEIN-COUPLED; RECOMBINANT FUSION PROTEINS; TWO-HYBRID SYSTEM TECHNIQUES;

MAMMALIA; MUS;

EID: 70449528326     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2009.08.007     Document Type: Article

References (48)

1. Aloy E.M., Weinmann O., Pot C., Kasper H., Dodd D.A., Rulicke T., Rossi F., and Schwab M.E. Synaptic destabilization by neuronal Nogo-A. Brain Cell Biol. 35 (2006) 137-156
2. Bartel P.L., Chien C.-T., Sternglanz R., and Fields S. Using the two-hybrid system to detect protein-protein interactions. In: Hartley A. (Ed). Cellular Interactions in Development: A Practical Approach (1993), Oxford University Press, Oxford 153-179
3. Bhattacharyya S., Luan J., Challis B., Keogh J., Montague C., Brennand J., Morten J., Lowenbeim S., Jenkins S., Farooqi I.S., Wareham N.J., and O'Rahilly S. Sequence variants in the melatonin-related receptor gene (GPR50) associate with circulating triglyceride and HDL levels. J. Lipid Res. 47 (2006) 761-766
4. Bradshaw N.J., Ogawa F., Antolin-Fontes B., Chubb J.E., Carlyle B.C., Christie S., Claessens A., Porteous D.J., and Millar J.K. DISC1, PDE4B, and NDE1 at the centrosome and synapse. Biochem. Biophys. Res. Commun. 377 (2008) 1091-1096
5. Camargo L.M., Collura V., Rain J.C., Mizuguchi K., Hermjakob H., Kerrien S., Bonnert T.P., Whiting P.J., and Brandon N.J. Disrupted in schizophrenia 1 interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia. Mol. Psychiatry 12 (2007) 74-86
6. Carlin R.K., Grab D.J., Cohen R.S., and Siekevitz P. Isolation and characterization of postsynaptic densities from various brain regions: enrichment of different types of postsynaptic densities. J. Cell Biol. 86 (1980) 831-845
7. Chen M.S., Huber A.B., van der Haar M.E., Frank M., Schnell L., Spillmann A.A., Christ F., and Schwab M.E. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 403 (2000) 434-439
8. Cho K.O., Hunt C.A., and Kennedy M.B. The rat brain postsynaptic density fraction contains a homolog of the Drosophila discs-large tumor suppressor protein. Neuron 9 (1992) 929-942
9. Clapcote S.J., Lipina T.V., Millar J.K., Mackie S., Christie S., Ogawa F., Lerch J.P., Trimble K., Uchiyama M., Sakuraba Y., Kaneda H., Shiroishi T., Houslay M.D., Henkelman R.M., Sled J.G., Gondo Y., Porteous D.J., and Roder J.C. Behavioral phenotypes of Disc1 missense mutations in mice. Neuron 54 (2007) 387-402
10. Dodd D.A., Niederoest B., Bloechlinger S., Dupuis L., Loeffler J.P., and Schwab M.E. Nogo-A, -B, and -C are found on the cell surface and interact together in many different cell types. J. Biol. Chem. 280 (2005) 12494-12502
11. Drew J.E., Barrett P., Mercer J.G., Moar K.M., Canet E., Delagrange P., and Morgan P.J. Localization of the melatonin-related receptor in the rodent brain and peripheral tissues. J. Neuroendocrinol. 13 (2001) 453-458
12. Dufourny L., Levasseur A., Migaud M., Callebaut I., Pontarotti P., Malpaux B., and Monget P. GPR50 is the mammalian ortholog of Mel1c: evidence of rapid evolution in mammals. BMC Evol. Biol. 8 (2008) 105
13. Formstecher E., Aresta S., Collura V., Hamburger A., Meil A., Trehin A., Reverdy C., Betin V., Maire S., Brun C., Jacq B., Arpin M., Bellaiche Y., Bellusci S., Benaroch P., Bornens M., Chanet R., Chavrier P., Delattre O., Doye V., Fehon R., Faye G., Galli T., Girault J.A., Goud B., de Gunzburg J., Johannes L., Junier M.P., Mirouse V., Mukherjee A., Papadopoulo D., Perez F., Plessis A., Rosse C., Saule S., Stoppa-Lyonnet D., Vincent A., White M., Legrain P., Wojcik J., Camonis J., and Daviet L. Protein interaction mapping: a Drosophila case study. Genome Res. 15 (2005) 376-384
14. Fournier A.E., GrandPre T., and Strittmatter S.M. Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature 409 (2001) 341-346
15. Fournier A.E., Takizawa B.T., and Strittmatter S.M. Rho kinase inhibition enhances axonal regeneration in the injured CNS. J. Neurosci. 23 (2003) 1416-1423
16. Fromont-Racine M., Rain J.C., and Legrain P. Toward a functional analysis of the yeast genome through exhaustive two-hybrid screens. Nat. Genet. 16 (1997) 277-282
17. Gil V., Nicolas O., Mingorance A., Urena J.M., Tang B.L., Hirata T., Saez-Valero J., Ferrer I., Soriano E., and del Rio J.A. Nogo-A expression in the human hippocampus in normal aging and in Alzheimer disease. J. Neuropathol. Exp. Neurol. 65 (2006) 433-444
18. GrandPre T., Nakamura F., Vartanian T., and Strittmatter S.M. Identification of the Nogo inhibitor of axon regeneration as a reticulon protein. Nature 403 (2000) 439-444
19. Hamouda H.O., Chen P., Levoye A., Sozer-Topcular N., Daulat A.M., Guillaume J.L., Ravid R., Savaskan E., Ferry G., Boutin J.A., Delagrange P., Jockers R., and Maurice P. Detection of the human GPR50 orphan seven transmembrane protein by polyclonal antibodies mapping different epitopes. J. Pineal. Res. 43 (2007) 10-15
20. Henstridge C.M., Balenga N.A., Ford L.A., Ross R.A., Waldhoer M., and Irving A.J. The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation. FASEB J. 23 (2009) 183-193
21. Ivanova E.A., Bechtold D.A., Dupre S.M., Brennand J., Barrett P., Luckman S.M., and Loudon A.S. Altered metabolism in the melatonin-related receptor (GPR50) knockout mouse. Am. J. Physiol. Endocrinol. Metab. 294 (2008) E176-E182
22. Lee C.W., Rivera R., Gardell S., Dubin A.E., and Chun J. GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5. J. Biol. Chem. 281 (2006) 23589-23597
23. Lee H., Raiker S.J., Venkatesh K., Geary R., Robak L.A., Zhang Y., Yeh H.H., Shrager P., and Giger R.J. Synaptic function for the Nogo-66 receptor NgR1: regulation of dendritic spine morphology and activity-dependent synaptic strength. J. Neurosci. 28 (2008) 2753-2765
24. Levoye A., Dam J., Ayoub M.A., Guillaume J.L., Couturier C., Delagrange P., and Jockers R. The orphan GPR50 receptor specifically inhibits MT1 melatonin receptor function through heterodimerization. EMBO J. 25 (2006) 3012-3023
25. Li Q., Lau A., Morris T.J., Guo L., Fordyce C.B., and Stanley E.F. A syntaxin 1, Galpha(o), and N-type calcium channel complex at a presynaptic nerve terminal: analysis by quantitative immunocolocalization. J. Neurosci. 24 (2004) 4070-4081
26. Lundstrom K. Latest development in drug discovery on G protein-coupled receptors. Curr Protein Pept. Sci. 7 (2006) 465-470
27. Manders E.E.M., Verbeek F.J., and Aten J.A. Measurement of co-localization of objects in dual-colour confocal images. J. Microsc. 169 (1993) 375-382
28. Mattila P.K., and Lappalainen P. Filopodia: molecular architecture and cellular functions. Nat. Rev. 9 (2008) 446-454
29. Mingorance A., Fontana X., Sole M., Burgaya F., Urena J.M., Teng F.Y., Tang B.L., Hunt D., Anderson P.N., Bethea J.R., Schwab M.E., Soriano E., and del Rio J.A. Regulation of Nogo and Nogo receptor during the development of the entorhino-hippocampal pathway and after adult hippocampal lesions. Mol. Cell. Neurosci. 26 (2004) 34-49
30. Mingorance-Le Meur A., Zheng B., Soriano E., and del Rio J.A. Involvement of the myelin-associated inhibitor Nogo-A in early cortical development and neuronal maturation. Cereb. Cortex 17 (2007) 2375-2386
31. Montani L., Gerrits B., Gehrig P., Kempf A., Dimou L., Wollscheid B., and Schwab M.E. Neuronal Nogo-A modulates growth cone motility via Rho-GTP/LIMK1/Cofilin in the unlesioned adult nervous system. J. Biol. Chem. 284 (2009) 10793-10807
32. Niederöst B., Oertle T., Fritsche J., McKinney R.A., and Bandtlow C.E. Nogo-A and myelin-associated glycoprotein mediate neurite growth inhibition by antagonistic regulation of RhoA and Rac1. J. Neurosci. 22 (2002) 10368-10376
33. Niethammer M., Smith D.S., Ayala R., Peng J., Ko J., Lee M.S., Morabito M., and Tsai L.H. NUDEL is a novel Cdk5 substrate that associates with LIS1 and cytoplasmic dynein. Neuron 28 (2000) 697-711
34. Novak G., Kim D., Seeman P., and Tallerico T. Schizophrenia and Nogo: elevated mRNA in cortex, and high prevalence of a homozygous CAA insert. Brain Res. 107 (2002) 183-189
35. Oertle T., and Schwab M.E. Nogo and its paRTNers. Trends Cell Biol. 13 (2003) 187-194
36. Oertle T., Huber C., van der Putten H., and Schwab M.E. Genomic structure and functional characterisation of the promoters of human and mouse nogo/rtn4. J. Mol. Biol. 325 (2003) 299-323
37. Oertle T., van der Haar M.E., Bandtlow C.E., Robeva A., Burfeind P., Buss A., Huber A.B., Simonen M., Schnell L., Brosamle C., Kaupmann K., Vallon R., and Schwab M.E. Nogo-A inhibits neurite outgrowth and cell spreading with three discrete regions. J. Neurosci. 23 (2003) 5393-5406
38. Okabe T., Nakamura T., Nishimura Y.N., Kohu K., Ohwada S., Morishita Y., and Akiyama T. RICS, a novel GTPase-activating protein for Cdc42 and Rac1, is involved in the beta-catenin-N-cadherin and N-methyl-d-aspartate receptor signaling. J. Biol. Chem. 278 (2003) 9920-9927
39. Reppert S.M., Weaver D.R., Ebisawa T., Mahle C.D., and Kolakowski Jr. L.F. Cloning of a melatonin-related receptor from human pituitary. FEBS Lett. 386 (1996) 219-224
40. Richard M., Giannetti N., Saucier D., Sacquet J., Jourdan F., and Pellier-Monnin V. Neuronal expression of Nogo-A mRNA and protein during neurite outgrowth in the developing rat olfactory system. Eur. J. Neurosci. 22 (2005) 2145-2158
41. Satoh J., Onoue H., Arima K., and Yamamura T. Nogo-A and nogo receptor expression in demyelinating lesions of multiple sclerosis. J. Neuropathol. Exp. Neurol. 64 (2005) 129-138
42. Schwab M.E. Nogo and axon regeneration. Curr. Opin. Neurobiol. 14 (2004) 118-124
43. Tan E.C., Chong S.A., Wang H., Chew-Ping Lim E., and Teo Y.Y. Gender-specific association of insertion/deletion polymorphisms in the nogo gene and chronic schizophrenia. Brain Res. 139 (2005) 212-216
44. Taya S., Shinoda T., Tsuboi D., Asaki J., Nagai K., Hikita T., Kuroda S., Kuroda K., Shimizu M., Hirotsune S., Iwamatsu A., and Kaibuchi K. DISC1 regulates the transport of the NUDEL/LIS1/14-3-3epsilon complex through kinesin-1. J. Neurosci. 27 (2007) 15-26
45. Thomson P.A., Wray N.R., Thomson A.M., Dunbar D.R., Grassie M.A., Condie A., Walker M.T., Smith D.J., Pulford D.J., Muir W., Blackwood D.H., and Porteous D.J. Sex-specific association between bipolar affective disorder in women and GPR50, an X-linked orphan G protein-coupled receptor. Mol. Psychiatry 10 (2005) 470-478
46. Vojtek A.B., and Hollenberg S.M. Ras-Raf interaction: two-hybrid analysis. Methods Enzymol. 255 (1995) 331-342
47. Wojcik S., Engel W.K., Yan R., McFerrin J., and Askanas V. NOGO is increased and binds to BACE1 in sporadic inclusion-body myositis and in A beta PP-overexpressing cultured human muscle fibers. Acta Neuropathol. 114 (2007) 517-526
48. Zhang B., Schmoyer D., Kirov S., and Snoddy J. GOTree machine (GOTM): a web-based platform for interpreting sets of interesting genes using gene ontology hierarchies. BMC Bioinformatics 5 (2004) 16